Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update

Journal of Clinical Oncology

Volumn 32, Issue 13, 2014, Pages 1365-1383

  Lyman, Gary H ^a   Temin, Sarah ^b   Edge, Stephen B ^c   Newman, Lisa A ^d   Turner, Roderick R ^e   Weaver, Donald L ^h   Benson III, Al B ⁱ   Bosserman, Linda D ^f   Burstein, Harold J ^j   Cody III, Hiram ^k   Hayman, James ^d   Perkins, Cheryl L ^l   Podoloff, Donald A ^m   Giuliano, Armando E ^g  

^a Fred Hutchinson Cancer Research Center   (United States)

^b AMERICAN SOCIETY OF CLINICAL ONCOLOGY   (United States)

^c BAPTIST CANCER CENTER   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e JOHN WAYNE CANCER INSTITUTE   (United States)

^f Wilshire Oncology Medical Group   (United States)

^g CEDARS SINAI MEDICAL CENTER   (United States)

^h UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

ⁱ NORTHWESTERN UNIVERSITY   (United States)

^j DANA FARBER CANCER INSTITUTE   (United States)

^k MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^l Patient Representative   (United States)

^m UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AXILLARY LYMPH NODE; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL PRACTICE; COHORT ANALYSIS; EVIDENCE BASED PRACTICE; HUMAN; INFLAMMATORY BREAST CANCER; INTRADUCTAL CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MASTECTOMY; ONCOLOGIST; PARTIAL MASTECTOMY; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE BIOPSY; SYSTEMATIC REVIEW; ARTICLE; BREAST TUMOR; CANCER STAGING; FEMALE; LYMPH NODE; METHODOLOGY; ONCOLOGY; PATHOLOGY; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARD;

BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; MEDICAL ONCOLOGY; NEOPLASM STAGING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENTINEL LYMPH NODE BIOPSY;

EID: 84900421315     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.54.1177     Document Type: Review

References (50)

1. Veronesi U, Paganelli G, Viale G, et al: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546-553, 2003 (Pubitemid 36951366)
2. Shiffman RN, Michel G, Rosenfeld RM, et al: Building better guidelines with BRIDGE-Wiz: Development and evaluation of a software assistant to promote clarity, transparency, and implementability. J Am Med Inform Assoc 19:94-101, 2012
3. Canavese G, Catturich A, Vecchio C, et al: Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: Results of randomized trial. Ann Oncol 20:1001-1007, 2009
4. Giuliano AE, Hunt KK, Ballman KV, et al: Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: A randomized clinical trial. JAMA 305:569-575, 2011
5. Mansel RE, Fallowfield L, Kissin M, et al: Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC trial. J Natl Cancer Inst 98:599-609, 2006 (Pubitemid 43904843)
6. Zavagno G, De Salvo GL, Scalco G, et al: A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: Results of the Sentinella/GIVOM trial. Ann Surg 247:207-213, 2008 (Pubitemid 351156760)
7. Smith MJ, Gill PG, Wetzig N, et al: Comparing patients' and clinicians' assessment of outcomes in a randomised trial of sentinel node biopsy for breast cancer (the RACS SNAC trial). Breast Cancer Res Treat 117:99-109, 2009
8. Ung OA: Australasian experience and trials in sentinel lymph node biopsy: The RACS SNAC trial. Asian J Surg 27:284-290, 2004
9. Veronesi U, Viale G, Paganelli G, et al: Sentinel lymph node biopsy in breast cancer: Ten-year results of a randomized controlled study. Ann Surg 251:595-600, 2010
10. Veronesi U, Paganelli G, Viale G, et al: Sentinel-lymph-node biopsy as a staging procedure in breast cancer: Update of a randomised controlled study. Lancet Oncol 7:983-990, 2006 (Pubitemid 44804136)
11. Purushotham AD, Upponi S, Klevesath MB, et al: Morbidity after sentinel lymph node biopsy in primary breast cancer: Results from a randomized controlled trial. J Clin Oncol 23:4312-4321, 2005 (Pubitemid 46209968)
12. Galimberti V, Cole BF, Zurrida S, et al: Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): A phase 3 randomised controlled trial. Lancet Oncol 14:297-305, 2013
13. Krag DN, Anderson SJ, Julian TB, et al: Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: Overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11:927-933, 2010
14. Weaver DL, Ashikaga T, Krag DN, et al: Effect of occult metastases on survival in node-negative breast cancer. N Engl J Med 364:412-421, 2011
15. Lyman GH, Giuliano AE, Somerfield MR, et al: American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23:7703-7720, 2005 (Pubitemid 46291835)
16. Krag DN, Anderson SJ, Julian TB, et al: Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: Results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8:881-888, 2007 (Pubitemid 47488052)
17. Harlow SP, Krag DN, Julian TB, et al: Prerandomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial: A randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer. Ann Surg 241:48-54, 2005 (Pubitemid 40040991)
18. Fleissig A, Fallowfield LJ, Langridge CI, et al: Post-operative arm morbidity and quality of life: Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 95:279-293, 2006
19. Goyal A, Newcombe RG, Chhabra A, et al: Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer: Results of the ALMANAC validation phase. Breast Cancer Res Treat 99:203-208, 2006 (Pubitemid 44268268)
20. Del Bianco P, Zavagno G, Burelli P, et al: Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: Results of the sentinella-GIVOM Italian randomised clinical trial. Eur J Surg Oncol 34:508-513, 2008 (Pubitemid 351514885)
21. Zavagno G, Del Bianco P, Koussis H, et al: Clinical impact of false-negative sentinel lymph nodes in breast cancer. Eur J Surg Oncol 34:620-625, 2008
22. Bochner MA, Kollias J, Gill PG, et al: Implication of intraoperative sentinel node imprint cytology for consent in the SNAC trial. ANZ J Surg 74:105-107, 2004 (Pubitemid 38437729)
23. Gill PG: Sentinel lymph node biopsy versus axillary clearance in operable breast cancer: The RACS SNAC trial, a multicenter randomized trial of the Royal Australian College of Surgeons (RACS) Section of Breast Surgery, in collaboration with the National Health and Medical Research Council Clinical Trials Center. Ann Surg Oncol 11:216S-221S, 2004 (suppl)
24. Ashikaga T, Krag DN, Land SR, et al: Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 102:111-118, 2010
25. Wilke LG, McCall LM, Posther KE, et al: Surgical complications associated with sentinel lymph node biopsy: Results from a prospective international cooperative group trial. Ann Surg Oncol 13:491-500, 2006
26. Lucci A, McCall LM, Beitsch PD, et al: Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25:3657-3663, 2007 (Pubitemid 47372604)
27. Olson JA Jr, McCall LM, Beitsch P, et al: Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: Results from American College of Surgeons Oncology Group Trials Z0010 and Z0011. J Clin Oncol 26:3530-3535, 2008
28. Goyal A, Horgan K, Kissin M, et al: Sentinel lymph node biopsy in male breast cancer patients. Eur J Surg Oncol 30:480-483, 2004 (Pubitemid 38701867)
29. Meretoja TJ, Leidenius MH, Heikkilä PS, et al: Sentinel node biopsy in breast cancer patients with large or multifocal tumors. Ann Surg Oncol 16:1148-1155, 2009
30. Knauer M, Konstantiniuk P, Haid A, et al: Multicentric breast cancer: A new indication for sentinel node biopsy-A multi-institutional validation study. J Clin Oncol 24:3374-3380, 2006 (Pubitemid 46638892)
31. Virnig BA, Tuttle TM, Shamliyan T, et al: Ductal carcinoma in situ of the breast: A systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst 102:170-178, 2010
32. Celebioglu F, Frisell J, Danielsson R, et al: Sentinel node biopsy in non-palpable breast cancer and in patients with a previous diagnostic excision. Eur J Surg Oncol 33:276-280, 2007 (Pubitemid 46488672)
33. Heuts EM, van der Ent FW, Kengen RA, et al: Results of sentinel node biopsy not affected by previous excisional biopsy. Eur J Surg Oncol 32:278-281, 2006
34. Lee S, Kim EY, Kang SH, et al: Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients. Breast Cancer Res Treat 102:283-288, 2007 (Pubitemid 46474835)
35. Patel NA, Piper G, Patel JA, et al: Accurate axillary nodal staging can be achieved after neoadjuvant therapy for locally advanced breast cancer. Am Surg 70:696-699, 2004; discussion 699-700
36. Canavese G, Dozin B, Vecchio C, et al: Accuracy of sentinel lymph node biopsy after neo-adjuvant chemotherapy in patients with locally advanced breast cancer and clinically positive axillary nodes. Eur J Surg Oncol 37:688-694, 2011
37. Stell VH, Flippo-Morton TS, James Norton H, et al: Sentinel lymph node biopsy after neo-adjuvant chemotherapy in breast cancer. Breast J 17:71-74, 2011
38. Mamounas EP, Brown A, Anderson S, et al: Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: Results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 23:2694-2702, 2005 (Pubitemid 46179459)
39. Kuehn T, Bauerfeind I, Fehm T, et al: Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): A prospective, multicentre cohort study. Lancet Oncol 14:609-618, 2013
40. Boughey JC, Suman VJ, Mittendorf EA, et al: Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: The ACOSOG Z1071 (Alliance) clinical trial. JAMA 310:1455-1461, 2013
41. Breslin TM, Cohen L, Sahin A, et al: Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 18:3480-3486, 2000
42. American Cancer Society: Cancer Facts and Figures for African Americans 2011-2012. Atlanta, GA, American Cancer Society, 2011
43. US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute: US Cancer Statistics Working Group: United States Cancer Statistics-1999-2008 Incidence and Mortality Web-Based Report. www.cdc.gov/uscs
44. Mead H, Cartwright-Smith L, Jones K, et al: Racial and Ethnic Disparities in U.S. Health Care: A Chartbook. New York, NY, The Commonwealth Fund, 2008
45. Howlader N, Noone AM, Krapcho M, et al (eds): SEER Cancer Statistics Review, 1975-2009 (vintage 2009 populations). Bethesda, MD, National Cancer Institute, 2012
46. Maloney N, Koch M, Erb D, et al: Impact of race on breast cancer in lower socioeconomic status women. Breast J 12:58-62, 2006 (Pubitemid 43381451)
47. Shah DR, Canter RJ, Khatri VP, et al: Utilization of sentinel lymph node biopsy in patients with ductal carcinoma in situ undergoing mastectomy. Ann Surg Oncol 20:24-30, 2013
48. Reeder-Hayes KE, Bainbridge J, Meyer AM, et al: Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancer. Breast Cancer Res Treat 128:863-871, 2011
49. Halpern MT, Chen AY, Marlow NS, et al: Disparities in receipt of lymph node biopsy among early-stage female breast cancer patients. Ann Surg Oncol 16:562-570, 2009
50. Silber JH, Rosenbaum PR, Clark AS, et al: Characteristics associated with differences in survival among black and white women with breast cancer. JAMA 310:389-397, 2013